ArticleJAMIA open2025
Multi-modal prediction of extracorporeal support-a resource intensive therapy, utilizing a large national database.
Article in JAMIA open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence-guided tools in adult ECMO: Current advancements, emerging Trends and future directions.Perfusion · 2026Review
- Multi-modal pediatric critical care datamart for extracorporeal support prediction and decision support.JAMIA open · 2026Article
- Artificial intelligence and machine learning in acute respiratory distress syndrome management: recent advances.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Objective: Extracorporeal membrane oxygenation (ECMO) is among the most resource-intensive therapies in critical care. The COVID-19 pandemic highlighted the lack of ECMO resource allocation tools. We aimed to develop a continuous ECMO risk prediction model to enhance patient triage and resource allocation. Material and Methods: We leveraged multimodal data from the National COVID Cohort Collaborative (N3C) to develop a hierarchical deep learning model, labeled "PreEMPT-ECMO" (Prediction, Early Monitoring, and Proactive Triage for ECMO) which integrates static and multi-granularity time series features to generate continuous predictions of ECMO utilization. Model performance was assessed across time points ranging from 0 to 96 hours prior to ECMO initiation, using both accuracy and precision metrics. Results: Between January 2020 and May 2023, 101 400 patients were included, with 1298 (1.28%) supported on ECMO. PreEMPT-ECMO outperformed established predictive models, including Logistic Regression, Support Vector Machine, Random Forest, and Extreme Gradient Boosting Tree, in both accuracy and precision at all time points. Model interpretation analysis also highlighted variations in feature contributions through each patient's clinical course. Discussion and Conclusions: We developed a hierarchical model for continuous ECMO use prediction, utilizing a large multicenter dataset incorporating both static and time series variables of various granularities. This novel approach reflects the nuanced decision-making process inherent in ECMO initiation and has the potential to be used as an early alert tool to guide patient triage and ECMO resource allocation. Future directions include prospective validation and generalizability on non-COVID-19 refractory respiratory failure, aiming to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.